Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. Published May 9, 2019 by the US Department of Health.
Editors' Pick
Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations. Published May 9, 2019 by the US Department of Health.
The Comprehensive Addiction and Recovery Act of 2016 (CARA) required the Pain Management Best Practices Inter-Agency Task Force to develop the Report on Pain Management Best Practices: Updates, Gaps, Inconsistencies, and Recommendations, which identified gaps or inconsistencies, and proposed updates to best practices and recommendations for pain management, including chronic and acute pain.
International Association for the Study of Pain
1510 H Street N.W., Suite 600
Washington, D.C. 20005-1020
1510 H Street N.W., Suite 600
Washington, D.C. 20005-1020
The IASP Pain Research Forum is a publication of the International Association for the Study of Pain
All site content, except where otherwise noted, is licensed under a Creative Commons BY-NC-ND License. Additional permissions for appropriate reuse available on request.
Comments
Howard Fields, University of California San Francisco
Because of the epidemic of
Because of the epidemic of opioid overdose and the potential contribution of prescription opioid analgesics, the United States Congress mandated a multidisciplinary task force to develop recommendations for clinical best practices in the management of chronic pain. This report is a result of the work of that Task Force. It is a well-documented and fairly comprehensive overview of current practice, with recommendations that, if implemented, will definitely improve the care of many patients currently suffering from chronic non-malignant pain. These guidelines are focused on chronic pain but include a discussion of acute pain management as well. Of particular interest is a final section discussing the value of the earlier guidelines for opioid use disseminated by the Centers for Disease Control. The CDC has now recognized that many patients have been harmed by misinterpretation of those guidelines leading to involuntary discontinuation of their opioid analgesics.